Zocor

Researchers 'stunned' to find approved cholesterol drug has negligible effect

The National Institutes of Health announced it is ending its study of the cholesterol drug Niaspan 18 months early. Tracking results showed the medication had almost no chance of being beneficial to patients, researchers found.